EQL Pharma AB (publ) (STO:EQL)
Sweden · Delayed Price · Currency is SEK 26.50
+1.20 (4.74%)
At close: Sep 3, 2026
EQL Pharma AB Employees
EQL Pharma AB had 65 employees as of June 30, 2026. The number of employees increased by 42 or 182.61% since the number was last reported on March 31, 2026.
Employees
65
Change
42
Growth
182.61%
Revenue / Employee
6.65M SEK
Profits / Employee
-216.05K SEK
Market Cap
769.25M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 65 | 42 | 182.61% |
| Mar 31, 2026 | 23 | 2 | 9.52% |
| Mar 31, 2025 | 21 | 0 | - |
| Mar 31, 2024 | 21 | 3 | 16.67% |
| Mar 31, 2023 | 18 | 5 | 38.46% |
| Mar 31, 2022 | 13 | 3 | 30.00% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioGaia AB | 251 |
| Orexo AB | 61 |
| Enzymatica AB | 18 |
| Cinclus Pharma Holding AB | 17 |
| Nanexa AB | 17 |
| Cereno Scientific AB | 10 |
| Newbury Pharmaceuticals AB | 7 |
| Moberg Pharma AB | 5 |
EQL Pharma AB News
- 4 days ago - EQL Pharma AB Transcript: DNB Carnegie Micro Cap Day Conference - Transcripts
- 4 weeks ago - EQL Pharma AB Transcript: Q1 26/27 - Transcripts
- 4 weeks ago - EQL Pharma AB Quarterly report: Q1 2027 - Filings
- 4 weeks ago - EQL Pharma AB Slides: Q1 2027 - Filings
- 3 months ago - EQL Pharma AB Transcript: Q4 25/26 - Transcripts
- 3 months ago - EQL Pharma AB Quarterly report: Q4 2026 - Filings
- 3 months ago - EQL Pharma AB Annual report: Q4 2026 - Filings
- 7 months ago - EQL Pharma AB Transcript: Q3 25/26 - Transcripts